Metabolism - Clinical and Experimental
Volume 60, Issue 2 , Pages 195-205, February 2011

Effects of glucose or fat calories in total parenteral nutrition on fat metabolism and systemic inflammation in rats

  • Pei-Ra Ling

      Affiliations

    • Laboratory of Nutrition/Infection, Beth Israel Deaconess Medical Center, Boston, MA 02215, USA
  • ,
  • Charlotte Andersson

      Affiliations

    • Laboratory of Nutrition/Infection, Beth Israel Deaconess Medical Center, Boston, MA 02215, USA
  • ,
  • Robert Strijbosch

      Affiliations

    • Department of Surgery and The Vascular Biology Program, Children's Hospital Boston, Harvard Medical School, Boston, MA 02215, USA
  • ,
  • Sang Lee

      Affiliations

    • Department of Surgery and The Vascular Biology Program, Children's Hospital Boston, Harvard Medical School, Boston, MA 02215, USA
  • ,
  • Anthony Silvestri

      Affiliations

    • Laboratory of Nutrition/Infection, Beth Israel Deaconess Medical Center, Boston, MA 02215, USA
  • ,
  • Kathleen M. Gura

      Affiliations

    • Department of Surgery and The Vascular Biology Program, Children's Hospital Boston, Harvard Medical School, Boston, MA 02215, USA
  • ,
  • Mark Puder

      Affiliations

    • Department of Surgery and The Vascular Biology Program, Children's Hospital Boston, Harvard Medical School, Boston, MA 02215, USA
  • ,
  • Bruce R. Bistrian

      Affiliations

    • Laboratory of Nutrition/Infection, Beth Israel Deaconess Medical Center, Boston, MA 02215, USA
    • Corresponding Author InformationCorresponding author. Tel.: +1 617 632 8545; fax: +1 617 632 0204.

Received 9 September 2009; accepted 14 December 2009. published online 25 January 2010.

Abstract 

This study compared the effects of total parenteral nutrition (TPN) by central vein with or without fat provided at maintenance energy requirement on fatty acid metabolism, de novo lipogenesis, and the risk of hepatic and systemic inflammation in rats. Study 1 was conducted in 2 groups: high glucose (HG), where fat-free TPN was given at maintenance levels of 180 kcal/(kg d), and low glucose (LG), where fat-free TPN containing 30% fewer calories at 126 kcal/(kg d) was provided by reducing 54 kcal/(kg d) from parenteral glucose. Study 2 contained 3 TPN groups: 1 LG group at 126 kcal/(kg d) and 2 groups at 180 kcal/(kg d) with 30% of total calories (54 kcal/[kg d]) either from soybean or fish oil emulsion. In both studies, animals fed a chow diet ad libitum were included. Plasma and hepatic triglyceride and phospholipid fatty acid profiles, enzymes indicating hepatic injury, and C-reactive protein levels (CRP) reflecting systemic injury were measured. In study 1, evidence of de novo lipogenesis was noted in LG and was more prominent in HG with elevation of CRP in HG. In study 2, de novo lipogenesis was reduced by adding either fat to LG to achieve maintenance energy levels. Moreover, adding fat as soybean oil but not fish oil significantly increased plasma and hepatic triglyceride and also elevated aspartate aminotransferase and CRP levels, reflecting inflammation. Thus, in rats, either hypocaloric feeding as glucose-based TPN or TPN provided at maintenance energy levels with the addition of fish oil limits hepatic lipid accumulation and prevents the evidence of hepatic and systemic injury found with maintenance level TPN as glucose only or glucose plus soybean oil.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Conflicts: Children's Hospital Boston has submitted a patent for Omegaven on behalf of Drs Gura and Puder. Dr Bistrian receives patent royalties through Beth Israel Deaconess Medical Center from Abbott and Nestle.

PII: S0026-0495(09)00526-5

doi:10.1016/j.metabol.2009.12.014

Metabolism - Clinical and Experimental
Volume 60, Issue 2 , Pages 195-205, February 2011